Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Skarbaliene J, Madsen AN, Mouritzen U, Bak HH, Just R (2017) Exploring the therapeutic potential of Glucagon/GLP-1 dual agonist ZP2929 in a mouse model of diet induced and biopsy-confirmed non-alcoholic steatohepatitis
GLP-1 medications belong to a class of prescription drugs that act by mimicking the action of a natural hormone in the body known as glucagon-like peptide-1 (GLP-1)
L-arginine is the precursor for the synthesis of nitric oxide (NO)
Skin barrier damage and itch: review of mechanisms, topical management and future directions
Further study of this model and this subgroup of ASD patients should improve our understanding of the pathophysiology and potential risk factors that lead to the metabolic, brain and behavior abnormalities associated with ASD
D., & Fuh, K
US$ 26.37
US$ 24.71
US$ 24.00
US$ 23.65
US$ 27.13
